CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-19). The draft was written by AI, the existence of all 5 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 600 · Search date 2026-07-19 · Methodology v0.6

Coffea cruda 30C,
does it really help with Relief of insomnia caused by racing thoughts?

30-Second Summary
F
Evidence Grade F · 6 · Safety caution
No source molecule is expected in Coffea cruda 30C, and insomnia relief has not been demonstrated beyond placebo
What the
research shows
Coffea cruda 30C is rated F because it is a 10^-60 preparation made through thirty sequential 1:100 dilutions, leaving no source-coffee molecule expected in an ordinary dose, and insomnia relief has not been distinguished from placebo. A systematic review of homeopathy for insomnia found no significant between-group difference in any of four small low-quality randomized trials. A 54-person polysomnography study including Coffea cruda 30C was an exploratory physiological experiment in selected healthy students and did not demonstrate concurrent randomized placebo-controlled insomnia treatment or consistent subjective improvement. FDA states that no homeopathic product is approved for efficacy and safety, and labels identify these products as unevaluated.
What the
ads claim
Marketing says that because coffee keeps people awake, ultradiluted coffee induces sleep and quiets racing thoughts. The similarity principle cannot replace dose response, an active molecule, absorption, or clinical efficacy, and label listing is not FDA efficacy review.
*

Useful facts when choosing a product

  • The 30C designation means thirty repetitions of 1:100 dilution, producing a theoretical final dilution of 10^-60, so no starting coffee-source molecule is expected in an ordinary manufactured dose.
  • Pellets usually consist materially of carriers such as sucrose or lactose, so people restricting sugar, those sensitive to lactose, and households with children should check the actual label and storage instructions.
  • A homeopathic entry in FDA's label repository is unapproved label information submitted by a manufacturer and must not be interpreted as FDA review or approval of safety, efficacy, or quality.
  • Persistent insomnia or daytime impairment, depression or mania symptoms, snoring or apnea, or restless legs warrants evidence-based assessment and should not delay CBT-I or other effective treatment.
Gap Measurement · Verdict 600 · F 6
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Cooper and Relton 2010 searched multiple databases and found four placebo-controlled randomized trials of homeopathy for insomnia; all were small and low quality, and none showed a significant between-group difference. Bell 2011 enrolled 54 healthy adults aged 18 to 31 selected for a history of coffee-related insomnia and personality-scale traits, gave single-masked placebo first, and later randomized Coffea cruda 30C or Nux vomica 30C for exploratory polysomnography. It was not a concurrent parallel placebo comparison and did not test racing thoughts or sustained subjective improvement in clinical insomnia. Shang 2005 found results compatible with placebo when broader homeopathy evidence was restricted to less biased trials.

02

Why this is classified as F (6)

Coffea cruda 30C lacks active-molecule and dose plausibility, the insomnia-homeopathy review found no significant between-group result in any placebo-controlled trial, and exploratory Coffea 30C polysomnography did not establish clinical subjective improvement. Official regulatory material also identifies homeopathic products as unevaluated and unapproved, giving F with 6 points. Carrier, contamination, and treatment-delay concerns are separated under safety.

Counterpoint. Direct toxicity may be low for a correctly manufactured ultradilute pellet, but low toxicity is not efficacy. The main practical risk is delaying assessment of persistent insomnia and effective treatment.

Rejudgment record. New verdict — Applied absent active-molecule plausibility at 30C, no significant between-group effect in any placebo-controlled insomnia-homeopathy trial, no confirmed clinical subjective efficacy in exploratory Coffea 30C polysomnography, broader high-quality homeopathy refutation, and FDA unevaluated and unapproved conclusions

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Relief of insomnia caused by racing thoughtsFActive-molecule plausibility is absent at 30C, and placebo-controlled subjective clinical improvement has not been demonstrated.
Improved sleep onset and quality in general insomniaFThe systematic review of insomnia-homeopathy trials found no significant between-group difference in any trial.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Cooper KL, Relton C. 2010Systematic review of homeopathy for insomnia4Academic research at the University of SheffieldSleep duration, sleep quality, and insomnia symptomsNo randomized trial showed a statistically significant between-group difference, and efficacy was not demonstrated.Key synthesis of null clinical evidence
Bell IR et al. 2011Exploratory repeated-measures home polysomnography study28United States NCCAM R21 and K24 grants; first author disclosed consulting for a homeopathic manufacturerPolysomnographic stages, latency, total sleep time, and exploratory subjective scalesSelected polysomnographic differences were explored, but placebo was always given first, there was no concurrent control, and consistent subjective clinical insomnia benefit was not established.Direct exploratory 30C evidence, not confirmatory efficacy
Shang A et al. 2005Comparative meta-analysis of placebo-controlled homeopathy and conventional-medicine trials110Swiss public evaluation programCondition-specific clinical effectsEffects in less biased homeopathy trials were compatible with placebo.Class-wide refuting evidence
§

Receipt — 5 References

All 5 cited sources were verified for existence at the original page (as of 2026-07-19).

Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev. 2010;14(5):329-337. PMID: 20223686. DOI: 10.1016/j.smrv.2009.11.005.
checked
Bell IR, Howerter A, Jackson N, Aickin M, Baldwin CM, Bootzin RR. Effects of homeopathic medicines on polysomnographic sleep of young adults with histories of coffee-related insomnia. Sleep Med. 2011;12(5):505-511. PMID: 20673648. PMCID: PMC2972403. DOI: 10.1016/j.sleep.2010.03.013.
checked
Shang A, Huwiler-Müntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366(9487):726-732. PMID: 16125589. DOI: 10.1016/S0140-6736(05)67177-2.
checked
U.S. Food and Drug Administration. Homeopathic Products. Updated December 10, 2025. PMID: none. DOI: none.
checked
DailyMed. COFFEA CRUDA 30X—coffea cruda globule, unapproved homeopathic label. Updated May 20, 2025. PMID: none. DOI: none.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-19 · Corrections: none

Cite this verdict

Coffea cruda 30C x relief of racing-thought insomnia Evidence Grade F card
[Chamgap] Coffea cruda 30C x relief of racing-thought insomnia — Evidence Grade F·6. 5 cited sources checked. Source: https://chamgap.com/en/verdicts/sleep/coffea-cruda-30c-racing-thoughts-insomnia/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.